SLNO Soleno Therapeutics, Inc.Stock Price & Overview
$45.24
Charts
Quant Ranking
SLNO Analysis
SLNO News
Latest Headlines
Ratings Summary
People Also Follow
Similar to SLNO
ETFs Holding SLNO
SLNO Company Profile
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Extended-Release tablets, a once-daily oral tablet, which is in Phase III clinical trials for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California.
SLNO Revenue
SLNO Earnings Per Share
Earnings Estimates
Earnings Revisions
Valuation
Profitability
Momentum
Capital Structure
Dividends
SLNO Ownership
SLNO Peers
Risk
Technicals
Investor Presentations
SLNO SEC Filings
Press Releases
SLNO Income Statement
SLNO Balance Sheet
SLNO Cash Flow Statement
SLNO Long Term Solvency
Discover More
You may be interested in: